Skip to main content
. 2016 Mar 2;7(14):17442–17454. doi: 10.18632/oncotarget.7856

Figure 3. FRα expression in NSCLC and corresponding distant metastases.

Figure 3

1a: primary tumor containing adenocarcinoma without FRα expression (20x). 1b: corresponding distant metastasis of the bone with positive FRα expression (20x). 2a: primary tumor containing adenocarcinoma with positive FRα expression (20x). 2b: corresponding distant metastasis of the brain with positive FRα expression (20x).